A validation study of normoglycemia and dysglycemia indices as a diabetes risk model
Paola Vargas, Miguel Angel Moreles, Joaquin Pe\~na, Adriana Monroy

TL;DR
This study evaluates glucose indices derived from OGTT data to classify diabetes risk, demonstrating their effectiveness in distinguishing normoglycemic and dysglycemic individuals and supporting their use in diabetes risk assessment.
Contribution
It introduces and validates the use of Peak glucose concentration and glucose removal rate indices for diabetes risk classification using a support vector machine.
Findings
Classification success rate of 83% for distinguishing patient groups
Identification of population clusters related to diabetic conditions
Validation of Ackerman's model for glucose-insulin regulation
Abstract
In this work, we test the performance of Peak glucose concentration () and average of glucose removal rates (), as normoglycemia and dysglycemia indices on a population monitored at the Mexico General Hospital between the years 2017 - 2019. A total of 1911 volunteer patients at the Mexico General Hospital are considered. 1282 female patients age ranging from 17 to 80 years old, and 629 male patients age ranging from 18 to 79 years old. For each volunteer, OGTT data is gathered and indices are estimated in Ackerman's model. A binary separation of normoglycemic and disglycemic patients using a Support Vector Machine with a linear kernel is carried out. Classification indices are successful for 83\%. Population clusters on diabetic conditions and progression from Normoglycemic to T2DM may be concluded. The classification indices, and may be regarded as patient's…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsDiabetes Management and Research · Diabetes, Cardiovascular Risks, and Lipoproteins · Artificial Intelligence in Healthcare
